{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:31:28Z","timestamp":1793050288066,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["PROGRES Q40-09"],"award-info":[{"award-number":["PROGRES Q40-09"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00228-021-03148-3","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T15:12:49Z","timestamp":1620054769000},"page":"1553-1561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Trends and patterns in EU(7)-PIM prescribing to elderly patients in Germany"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6815-0780","authenticated-orcid":false,"given":"Iva","family":"Selke Krulichov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9614-9875","authenticated-orcid":false,"given":"Gisbert W.","family":"Selke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra A.","family":"Th\u00fcrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"key":"3148_CR1","unstructured":"Statistisches Bundesamt (Destatis) (2019) Bev\u00f6lkerungspyramide: Altersstruktur Deutschlands von 1950 - 2060. https:\/\/service.destatis.de\/bevoelkerungspyramide\/index.html#!y=2029&a=20,65&l=en&g. Accessed 24 Nov 2020"},{"key":"3148_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/14740338.2018.1415322","volume":"17","author":"S Schmiedl","year":"2018","unstructured":"Schmiedl S, Rottenkolber M, Szymanski J et al (2018) Preventable ADRs leading to hospitalization - results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients. Expert Opin Drug Saf 17:125\u2013137. https:\/\/doi.org\/10.1080\/14740338.2018.1415322","journal-title":"Expert Opin Drug Saf"},{"key":"3148_CR3","first-page":"29","volume":"274","author":"DW Bates","year":"1995","unstructured":"Bates DW, Cullen DJ, Laird N et al (1995) Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group JAMA 274:29\u201334","journal-title":"ADE Prevention Study Group JAMA"},{"key":"3148_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1136\/qhc.13.4.306","volume":"13","author":"T Morimoto","year":"2004","unstructured":"Morimoto T, Gandhi TK, Seger AC et al (2004) Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care 13:306\u2013314. https:\/\/doi.org\/10.1136\/qhc.13.4.306","journal-title":"Qual Saf Health Care"},{"key":"3148_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1517\/17425255.2015.1004310","volume":"11","author":"E Reeve","year":"2015","unstructured":"Reeve E, Wiese MD, Mangoni AA (2015) Alterations in drug disposition in older adults. Expert Opin Drug Metab Toxicol 11:491\u2013508. https:\/\/doi.org\/10.1517\/17425255.2015.1004310","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3148_CR6","doi-asserted-by":"publisher","unstructured":"Th\u00fcrmann\u00a0PA (2020) Clinical studies in geriatric population. Drug Discov Eval Methods Clin Pharmacol 417\u2013424.\u00a0https:\/\/doi.org\/10.1007\/978-3-319-68864-0_43","DOI":"10.1007\/978-3-319-68864-0_43"},{"key":"3148_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1365-2710.2007.00793.x","volume":"32","author":"P Gallagher","year":"2007","unstructured":"Gallagher P, Barry P, O\u2019Mahony D (2007) Inappropriate prescribing in the elderly. J Clin Pharm Ther 32:113\u2013121. https:\/\/doi.org\/10.1111\/j.1365-2710.2007.00793.x","journal-title":"J Clin Pharm Ther"},{"key":"3148_CR8","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1001\/archinte.1991.00400090107019","volume":"151","author":"MH Beers","year":"1991","unstructured":"Beers MH, Ouslander JG, Rollingher I et al (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 151:1825\u20131832","journal-title":"Arch Intern Med"},{"key":"3148_CR9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00228-018-2446-0","volume":"74","author":"FR Motter","year":"2018","unstructured":"Motter FR, Fritzen JS, Hilmer SN et al (2018) Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria. Eur J Clin Pharmacol 74:679\u2013700. https:\/\/doi.org\/10.1007\/s00228-018-2446-0","journal-title":"Eur J Clin Pharmacol"},{"key":"3148_CR10","doi-asserted-by":"publisher","first-page":"204209861985401","DOI":"10.1177\/2042098619854014","volume":"10","author":"D Fialov\u00e1","year":"2019","unstructured":"Fialov\u00e1 D, Brki\u0107 J, Laffon B et al (2019) Applicability of EU(7)-PIM criteria in cross-national studies in European countries. Ther Adv Drug Saf 10:2042098619854014. https:\/\/doi.org\/10.1177\/2042098619854014","journal-title":"Ther Adv Drug Saf"},{"key":"3148_CR11","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11096-019-00847-x","volume":"41","author":"N Wamil","year":"2019","unstructured":"Wamil N, Mattsson S, Gustafsson M (2019) Assessment of potentially inappropriate medications using the EU (7)-PIM list and the Swedish quality indicators. Int J Clin Pharm 41:903\u2013912. https:\/\/doi.org\/10.1007\/s11096-019-00847-x","journal-title":"Int J Clin Pharm"},{"key":"3148_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/jcpt.12494","volume":"42","author":"D Grina","year":"2017","unstructured":"Grina D, Briedis V (2017) The use of potentially inappropriate medications among the Lithuanian elderly according to Beers and EU(7)-PIM list - a nationwide cross-sectional study on reimbursement claims data. J Clin Pharm Ther 42:195\u2013200. https:\/\/doi.org\/10.1111\/jcpt.12494","journal-title":"J Clin Pharm Ther"},{"key":"3148_CR13","doi-asserted-by":"publisher","first-page":"e0226511","DOI":"10.1371\/journal.pone.0226511","volume":"14","author":"S Toepfer","year":"2019","unstructured":"Toepfer S, Bolbrinker J, K\u00f6nig M et al (2019) Potentially inappropriate medication in older participants of the Berlin Aging Study II (BASE-II) - sex differences and associations with morbidity and medication use. PLoS One 14:e0226511. https:\/\/doi.org\/10.1371\/journal.pone.0226511","journal-title":"PLoS One"},{"key":"3148_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3238\/arztebl.2010.0543","volume":"107","author":"S Holt","year":"2010","unstructured":"Holt S, Schmiedl S, Th\u00fcrmann PA (2010) Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arzteblatt Int 107:543\u2013551. https:\/\/doi.org\/10.3238\/arztebl.2010.0543","journal-title":"Dtsch Arzteblatt Int"},{"key":"3148_CR15","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1001\/archinte.1997.00440350031003","volume":"157","author":"MH Beers","year":"1997","unstructured":"Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. An update Arch Intern Med 157:1531\u20131536","journal-title":"An update Arch Intern Med"},{"key":"3148_CR16","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","volume":"163","author":"DM Fick","year":"2003","unstructured":"Fick DM, Cooper JW, Wade WE et al (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163:2716\u20132724. https:\/\/doi.org\/10.1001\/archinte.163.22.2716","journal-title":"Arch Intern Med"},{"key":"3148_CR17","first-page":"385","volume":"156","author":"PJ McLeod","year":"1997","unstructured":"McLeod PJ, Huang AR, Tamblyn RM, Gayton DC (1997) Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 156:385\u2013391","journal-title":"CMAJ"},{"key":"3148_CR18","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00228-007-0324-2","volume":"63","author":"M-L Laroche","year":"2007","unstructured":"Laroche M-L, Charmes J-P, Merle L (2007) Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 63:725\u2013731. https:\/\/doi.org\/10.1007\/s00228-007-0324-2","journal-title":"Eur J Clin Pharmacol"},{"key":"3148_CR19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00228-015-1860-9","volume":"71","author":"A Renom-Guiteras","year":"2015","unstructured":"Renom-Guiteras A, Meyer G, Th\u00fcrmann PA (2015) The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol 71:861\u2013875. https:\/\/doi.org\/10.1007\/s00228-015-1860-9","journal-title":"Eur J Clin Pharmacol"},{"key":"3148_CR20","unstructured":"Bundesministerium der Justiz und f\u00fcr Verbraucherschutz (2020) Sozialgesetzbuch - Elftes Buch, \u00a7 15. https:\/\/www.gesetze-im-internet.de\/sgb_11\/__15.html. Accessed 24 Nov 2020"},{"key":"3148_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/17512433.2017.1301206","volume":"10","author":"D Gnjidic","year":"2017","unstructured":"Gnjidic D, Tinetti M, Allore HG (2017) Assessing medication burden and polypharmacy: finding the perfect measure. Expert Rev Clin Pharmacol 10:345\u2013347. https:\/\/doi.org\/10.1080\/17512433.2017.1301206","journal-title":"Expert Rev Clin Pharmacol"},{"key":"3148_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000368191","volume":"61","author":"PS Nishtala","year":"2015","unstructured":"Nishtala PS, Salahudeen MS (2015) Temporal trends in polypharmacy and hyperpolypharmacy in older New Zealanders over a 9-year period: 2005\u20132013. Gerontology 61:195\u2013202. https:\/\/doi.org\/10.1159\/000368191","journal-title":"Gerontology"},{"key":"3148_CR23","unstructured":"Statistisches Bundesamt (Destatis) (2020) - GENESIS-Online. https:\/\/www-genesis.destatis.de\/genesis\/online. Accessed 24 Nov 2020"},{"key":"3148_CR24","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2147\/PPA.S247013","volume":"14","author":"C Monteiro","year":"2020","unstructured":"Monteiro C, Can\u00e1rio C, Ribeiro M\u00c2 et al (2020) Medication evaluation in Portuguese elderly patients according to beers, STOPP\/START criteria and EU(7)-PIM List - an exploratory study. Patient Prefer Adherence 14:795\u2013802. https:\/\/doi.org\/10.2147\/PPA.S247013","journal-title":"Patient Prefer Adherence"},{"key":"3148_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.archger.2018.12.013","volume":"81","author":"D Caldeira","year":"2019","unstructured":"Caldeira D, Nunes-Ferreira A, Rodrigues R et al (2019) Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: a systematic review with meta-analysis and trial sequential analysis. Arch Gerontol Geriatr 81:209\u2013214. https:\/\/doi.org\/10.1016\/j.archger.2018.12.013","journal-title":"Arch Gerontol Geriatr"},{"key":"3148_CR26","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3389\/fphar.2018.01220","volume":"9","author":"S Moudallel","year":"2018","unstructured":"Moudallel S, Steurbaut S, Cornu P, Dupont A (2018) Appropriateness of DOAC prescribing before and during hospital admission and analysis of determinants for inappropriate prescribing. Front Pharmacol 9:1220. https:\/\/doi.org\/10.3389\/fphar.2018.01220","journal-title":"Front Pharmacol"},{"key":"3148_CR27","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2019","unstructured":"American Geriatrics Society Beers Criteria\u00ae Update Expert Panel (2019) American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc 67:674\u2013694. https:\/\/doi.org\/10.1111\/jgs.15767","journal-title":"J Am Geriatr Soc"},{"key":"3148_CR28","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00228-017-2246-y","volume":"73","author":"I Mucalo","year":"2017","unstructured":"Mucalo I, Had\u017eiabdi\u0107 MO, Brajkovi\u0107 A et al (2017) Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol. Eur J Clin Pharmacol 73:991\u2013999. https:\/\/doi.org\/10.1007\/s00228-017-2246-y","journal-title":"Eur J Clin Pharmacol"},{"key":"3148_CR29","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/pds.3429","volume":"22","author":"I Schubert","year":"2013","unstructured":"Schubert I, K\u00fcpper-Nybelen J, Ihle P, Th\u00fcrmann P (2013) Prescribing potentially inappropriate medication (PIM) in Germany\u2019s elderly as indicated by the PRISCUS list. An analysis based on regional claims data. Pharmacoepidemiol Drug Saf 22:719\u2013727. https:\/\/doi.org\/10.1002\/pds.3429","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3148_CR30","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s00508-014-0589-2","volume":"126","author":"S Stock","year":"2014","unstructured":"Stock S, Redaelli M, Simic D et al (2014) Risk factors for the prescription of potentially inappropriate medication (PIM) in the elderly: an analysis of sickness fund routine claims data from Germany. Wien Klin Wochenschr 126:604\u2013612. https:\/\/doi.org\/10.1007\/s00508-014-0589-2","journal-title":"Wien Klin Wochenschr"},{"key":"3148_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/fampra\/cmz060","volume":"37","author":"B Roux","year":"2020","unstructured":"Roux B, Sirois C, Simard M et al (2020) Potentially inappropriate medications in older adults: a population-based cohort study. Fam Pract 37:173\u2013179. https:\/\/doi.org\/10.1093\/fampra\/cmz060","journal-title":"Fam Pract"},{"key":"3148_CR32","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00228-017-2218-2","volume":"73","author":"E S\u00f6nnerstam","year":"2017","unstructured":"S\u00f6nnerstam E, Sj\u00f6lander M, Gustafsson M (2017) An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list. Eur J Clin Pharmacol 73:735\u2013742. https:\/\/doi.org\/10.1007\/s00228-017-2218-2","journal-title":"Eur J Clin Pharmacol"},{"key":"3148_CR33","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/ijpp.12541","volume":"27","author":"SK Nothelle","year":"2019","unstructured":"Nothelle SK, Sharma R, Oakes A et al (2019) Factors associated with potentially inappropriate medication use in community-dwelling older adults in the United States: a systematic review. Int J Pharm Pract 27:408\u2013423. https:\/\/doi.org\/10.1111\/ijpp.12541","journal-title":"Int J Pharm Pract"},{"key":"3148_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2174\/1574884710666150609154741","volume":"10","author":"K Johnell","year":"2015","unstructured":"Johnell K (2015) Inappropriate drug use in people with cognitive impairment and dementia: a systematic review. Curr Clin Pharmacol 10:178\u2013184. https:\/\/doi.org\/10.2174\/1574884710666150609154741","journal-title":"Curr Clin Pharmacol"},{"key":"3148_CR35","first-page":"119","volume-title":"Pflege-Report 2017","author":"PA Th\u00fcrmann","year":"2017","unstructured":"Th\u00fcrmann PA (2017) Einsatz von Psychopharmaka bei Pflegebed\u00fcrftigen. In: Jacobs K, Kuhlmey A, Gre\u00df S, Klauber J, Schwinger A (eds) Pflege-Report 2017. Schattauer, Stuttgart, pp 119\u2013129"},{"key":"3148_CR36","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.3390\/ijerph17113892","volume":"17","author":"F Hoffmann","year":"2020","unstructured":"Hoffmann F, Bantel C, von Rosen FT, Jobski K (2020) Regional differences in prescribing patterns of metamizole in Germany based on data from 70 million persons. Int J Environ Res Public Health 17:3892. https:\/\/doi.org\/10.3390\/ijerph17113892","journal-title":"Int J Environ Res Public Health"},{"key":"3148_CR37","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/03007995.2018.1541317","volume":"35","author":"I Selke Krulichov\u00e1","year":"2019","unstructured":"Selke Krulichov\u00e1 I, Selke GW, Eichler U et al (2019) Impact of EU risk assessment process and administrative regulations for manufacturers of combined hormonal contraceptive prescribing. An analysis of developments in Germany and the implications. Curr Med Res Opin 35:697\u2013704. https:\/\/doi.org\/10.1080\/03007995.2018.1541317","journal-title":"Curr Med Res Opin"},{"key":"3148_CR38","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00391-019-01660-x","volume":"53","author":"K Gudd","year":"2020","unstructured":"Gudd K, Meier F, Lindenthal J et al (2020) Potenziell inad\u00e4quate Medikation in einem deutschen Praxisnetz \u2013 Wer verordnet was an wen? Z Gerontol Geriat 53:647\u2013654. https:\/\/doi.org\/10.1007\/s00391-019-01660-x","journal-title":"Z Gerontol Geriat"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03148-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-021-03148-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03148-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T08:07:17Z","timestamp":1631606837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-021-03148-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["3148"],"URL":"https:\/\/doi.org\/10.1007\/s00228-021-03148-3","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,3]]},"assertion":[{"value":"3 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}